Female bladder cancer: Incidence, treatment, and outcome

Current Opinion in Urology

Volumn 20, Issue 5, 2010, Pages 404-408

  Scosyrev, Emil ^a   Trivedi, Deep ^a   Messing, Edward ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

bladder cancer; incidence; mortality; sex disparity

Indexed keywords

BIOLOGICAL FACTOR;

ADVANCED CANCER; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; TUMOR DIFFERENTIATION;

FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; WOMEN'S HEALTH;

EID: 77955467763     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32833c7a9b     Document Type: Review

References (38)

1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27:289-293.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009. CA Cancer J Clin 2009; 59:225-249.
3. Horstmann M, Witthuhn R, Falk M, et al. Gender-specific differences in bladder cancer: A retrospective analysis. Gend Med 2008; 5:385-394.
4. Mungan AN, Aben KK, Schoenberg MP, et al. Gender differences in stageadjusted bladder cancer survival. Urology 2000; 55:876-880.
5. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009; 115:68-74.
6. Puente D, Malats N, Cecchini L, et al. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 2003; 43:53-62.
7. Marshall VF. Current clinical problems regarding bladder tumors. Cancer 1956; (3):543-550.
8. Kishi K, Hirota T, Matsumoto K, et al. Carcinoma of the bladder: A clinical and pathological analysis of 87 autopsy cases. J Urol 1981; 125:36-39.
9. Wright JL, Porter MP, Li CI, et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 2006; 107:721-728.
10. Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: Is survival different with stage adjustment? Urology 2009; 73:822-877.
11. El-Sebaie M, Zaghloul MS, Howard G, et al. Squamous cell carcinoma of the bilharzial and nonbilharzial urinary bladder: A review of etiological features, natural history, and management. Int J Clin Oncol 2005; 10:20-25.
12. Fiore MC, Novotny TE, Pierce JP, et al. Trends in cigarette smoking in the US: The changing influence of gender and race. JAMA 1989; 261:49-55.
13. Hartge P, Harvey EB, Linehan WN, et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 1990; 82:1636-1640.
14. Miyamoto H, Yang Z, Chen Y, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007; 99:558-568.
15. Boorjian SA, Heemers HV, Frank I, et al. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer 2009; 16:123-137.
16. Johnson AM, O'Connell MJ, Miyamoto H, et al. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-I. BMC Urol 2008; 8:7.
17. Tuygun C, Kankaya D, Imamoglu A, et al. Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 2009. [Epub ahead of print] This is the most recent study of the role of sex hormone receptors in bladder cancer.
18. Shen SS, Smith CL, Hsieh JT, et al. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 2006; 106:2610-2616.
19. McGrath M, Michaud DS, DeVivo I. Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 2005; 163: 236-244.
20. Cantwell MM, Lacey JV Jr, Schairer C, et al. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 2006; 119:2398-2401.
21. Gloeckler Ries LA, Reichman ME, Lewis DR, et al. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2003; 8:541-552.
22. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: Final data for 2002. Natl Vital Stat Rep 2004; 53:1-115.
23. Micheli A, Mariotto A, Giorgi Rossi A, et al. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 1998; 34:2271-2278.
24. Cárdenas-Turanzas M, Cooksley C, Pettaway CA, et al. Comparative outcomes of bladder cancer. Obstet Gynecol 2006; 108:169-175.
25. Johnson EK, Diagnaul S, Zhang Y, et al. Patterns of hematuria referral to urologists: Does a gender disparity exist? Urology 2008; 72:498-502.
26. Mungan A, Kiemeney L, van Dijck J, et al. Gender differences in stage distribution of bladder cancer. Urology 2000; 55:368-371.
27. Tilki D, Svatek RS, Karakiewicz PL, et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: A retrospective international study of 583 patients. J Urol 2010; 187:87-93. To our knowledge, this is the most thoroughly controlled study of the effect of sex on bladder cancer outcomes.
28. Herr RH, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol 2004; (22): 2781-2789.
29. Lotan Y, Gupta A, Shariat SH, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23:6533-6539.
30. Bolenz C, Herrmann E, Bastian PJ, et al. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph nodenegative urothelial bladder cancer treated by radical cystectomy: A multicentre validation trial. BJU Int 2010. [Epub ahead of print]
31. Schrag D, Mitra N, Xu F, et al. Cystectomy for muscle-invasive bladder cancer: Patterns and ouctomes of care in the medicare population. Urology 2005; 65:1118-1125.
32. Taub DA, Hollenbeck BK, Cooper KL, et al. Racial disparities in resource utilization for cystectomy. Urology 2006; 67:288-293.
33. Gore LJ, Kwan L, Saigal CS, et al. Marriage and mortality in bladder carcinoma. Cancer 2005; 104:1188-1194.
34. Datta GB, Neville BA, Kawachi I, et al. Marital status and survival following bladder cancer. J Epidemiol Community Health 2009; 63:807-813. This is a detailed analysis of mechanisms that may be responsible for the association of marital status with mortality among men and women with bladder cancer.
35. Pruthi RS, Lentz AC, Sand M, et al. Impact of marital status in patients undergoing radical cystectomy for bladder cancer. World J Urol 2009; 27:573-576.
36. Snyder C, Harlan L, Knopf K, et al. Patterns of care for the treatment of bladder cancer. J Urol 2003; 169:1697-1701.
37. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: An analysis of data from the SEER program. J Urol 2003; 170:1765-1771.
38. Gore JL, Lai J, Setodji CM, et al. Mortality increases when radical cystectomy is delayed more than 12 weeks. Cancer 2009; 115:988-996.